These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 17279354)

  • 1. C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport.
    D'Alessandris C; Lauro R; Presta I; Sesti G
    Diabetologia; 2007 Apr; 50(4):840-9. PubMed ID: 17279354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
    Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
    Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism.
    Miele C; Riboulet A; Maitan MA; Oriente F; Romano C; Formisano P; Giudicelli J; Beguinot F; Van Obberghen E
    J Biol Chem; 2003 Nov; 278(48):47376-87. PubMed ID: 12970360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells.
    Andreozzi F; D'Alessandris C; Federici M; Laratta E; Del Guerra S; Del Prato S; Marchetti P; Lauro R; Perticone F; Sesti G
    Endocrinology; 2004 Jun; 145(6):2845-57. PubMed ID: 15001544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels.
    Pedrini MT; Kranebitter M; Niederwanger A; Kaser S; Engl J; Debbage P; Huber LA; Patsch JR
    Diabetologia; 2005 Apr; 48(4):756-66. PubMed ID: 15747109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gly-->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells.
    Hribal ML; Federici M; Porzio O; Lauro D; Borboni P; Accili D; Lauro R; Sesti G
    J Clin Endocrinol Metab; 2000 May; 85(5):2004-13. PubMed ID: 10843189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in l6 rat skeletal muscle cells.
    Sweeney G; Keen J; Somwar R; Konrad D; Garg R; Klip A
    Endocrinology; 2001 Nov; 142(11):4806-12. PubMed ID: 11606447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes.
    Sasaoka T; Hori H; Wada T; Ishiki M; Haruta T; Ishihara H; Kobayashi M
    Diabetologia; 2001 Oct; 44(10):1258-67. PubMed ID: 11692174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
    Izawa Y; Yoshizumi M; Fujita Y; Ali N; Kanematsu Y; Ishizawa K; Tsuchiya K; Obata T; Ebina Y; Tomita S; Tamaki T
    Exp Cell Res; 2005 Aug; 308(2):291-9. PubMed ID: 15921682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells.
    Hajduch E; Balendran A; Batty IH; Litherland GJ; Blair AS; Downes CP; Hundal HS
    Diabetologia; 2001 Feb; 44(2):173-83. PubMed ID: 11270673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells.
    Andreozzi F; Laratta E; Procopio C; Hribal ML; Sciacqua A; Perticone M; Miele C; Perticone F; Sesti G
    Mol Cell Biol; 2007 Mar; 27(6):2372-83. PubMed ID: 17242212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
    Dokken BB; Sloniger JA; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of insulin signalling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin.
    Palanivel R; Maida A; Liu Y; Sweeney G
    Diabetologia; 2006 Jan; 49(1):183-90. PubMed ID: 16341686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats.
    Henriksen EJ; Teachey MK
    Metabolism; 2007 Jul; 56(7):931-8. PubMed ID: 17570255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine modulates phosphorylation of insulin receptor substrate-1 and impairs insulin signal transduction in rat skeletal muscle.
    Egawa T; Tsuda S; Ma X; Hamada T; Hayashi T
    J Appl Physiol (1985); 2011 Dec; 111(6):1629-36. PubMed ID: 21940847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.
    Li YY; Shi ZM; Yu XY; Feng P; Wang XJ
    World J Gastroenterol; 2016 Jul; 22(25):5769-79. PubMed ID: 27433090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HM-Chromanone, a Major Homoisoflavonoid in
    Park JE; Han JS
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of mitochondrial DNA causes impaired glucose utilization and insulin resistance in L6 GLUT4myc myocytes.
    Park SY; Choi GH; Choi HI; Ryu J; Jung CY; Lee W
    J Biol Chem; 2005 Mar; 280(11):9855-64. PubMed ID: 15764607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes.
    Bandyopadhyay G; Standaert ML; Galloway L; Moscat J; Farese RV
    Endocrinology; 1997 Nov; 138(11):4721-31. PubMed ID: 9348199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin induces insulin resistance in L6 skeletal muscle myotubes by suppressing insulin signaling, GLUT4 expression and GSK-3β phosphorylation.
    Yaluri N; Modi S; Kokkola T
    Biochem Biophys Res Commun; 2016 Nov; 480(2):194-200. PubMed ID: 27743890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.